Quang X. Pham - 01 Sep 2023 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Quang Pham
Issuer symbol
CVKD
Transactions as of
01 Sep 2023
Net transactions value
+$63,945
Form type
4
Filing time
05 Sep 2023, 06:05:15 UTC
Previous filing
13 Feb 2023
Next filing
06 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVKD Common Stock Purchase $9,318 +10,000 +0.3% $0.9318 3,310,000 01 Sep 2023 Direct
transaction CVKD Common Stock Purchase $18,582 +20,000 +0.6% $0.9291 3,330,000 01 Sep 2023 Direct
transaction CVKD Common Stock Purchase $18,444 +20,000 +0.6% $0.9222 3,350,000 01 Sep 2023 Direct
transaction CVKD Common Stock Purchase $9,168 +10,000 +0.3% $0.9168 3,360,000 01 Sep 2023 Direct
transaction CVKD Common Stock Purchase $8,433 +10,000 +0.3% $0.8433 3,370,000 01 Sep 2023 Direct
holding CVKD Common Stock 3,000,000 01 Sep 2023 The PVBQ Living Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.